
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Operation Nasal Vaccine—Lightning speed to counter COVID-19
Eric J. Topol, Akiko Iwasaki
Science Immunology (2022) Vol. 7, Iss. 74
Closed Access | Times Cited: 81
Eric J. Topol, Akiko Iwasaki
Science Immunology (2022) Vol. 7, Iss. 74
Closed Access | Times Cited: 81
Showing 1-25 of 81 citing articles:
Acute and postacute sequelae associated with SARS-CoV-2 reinfection
Benjamin Bowe, Yan Xie, Ziyad Al‐Aly
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2398-2405
Open Access | Times Cited: 443
Benjamin Bowe, Yan Xie, Ziyad Al‐Aly
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2398-2405
Open Access | Times Cited: 443
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 348-357
Open Access | Times Cited: 156
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 348-357
Open Access | Times Cited: 156
Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 109
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 109
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 81
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 81
Solving the puzzle of Long Covid
Ziyad Al‐Aly, Eric J. Topol
Science (2024) Vol. 383, Iss. 6685, pp. 830-832
Closed Access | Times Cited: 65
Ziyad Al‐Aly, Eric J. Topol
Science (2024) Vol. 383, Iss. 6685, pp. 830-832
Closed Access | Times Cited: 65
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study
Jie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e579-e590
Open Access | Times Cited: 58
Jie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e579-e590
Open Access | Times Cited: 58
Immunological memory diversity in the human upper airway
Sydney I. Ramirez, Farhoud Faraji, L. Benjamin Hills, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 630-636
Closed Access | Times Cited: 26
Sydney I. Ramirez, Farhoud Faraji, L. Benjamin Hills, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 630-636
Closed Access | Times Cited: 26
Pulmonary inhalation for disease treatment: Basic research and clinical translations
Bin Wang, Lin Wang, Qian Yang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100966-100966
Open Access | Times Cited: 21
Bin Wang, Lin Wang, Qian Yang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100966-100966
Open Access | Times Cited: 21
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Julia M. Adler, Ricardo Martin Vidal, Christine Langner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Julia M. Adler, Ricardo Martin Vidal, Christine Langner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
When to update COVID-19 vaccine composition
Rebecca Grant, Jilian A. Sacks, Priya Abraham, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 776-780
Open Access | Times Cited: 38
Rebecca Grant, Jilian A. Sacks, Priya Abraham, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 776-780
Open Access | Times Cited: 38
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs
Andrew Farlow, Els Torreele, Glenda Gray, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 690-690
Open Access | Times Cited: 33
Andrew Farlow, Els Torreele, Glenda Gray, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 690-690
Open Access | Times Cited: 33
Biomaterials for intranasal and inhaled vaccine delivery
Devorah Cahn, Mayowa Amosu, Katharina Maisel, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 83-84
Open Access | Times Cited: 25
Devorah Cahn, Mayowa Amosu, Katharina Maisel, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 83-84
Open Access | Times Cited: 25
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 24
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 24
Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses
Wenjiao Fu, Mengyu Guo, Xuemei Zhou, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11200-11216
Closed Access | Times Cited: 12
Wenjiao Fu, Mengyu Guo, Xuemei Zhou, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11200-11216
Closed Access | Times Cited: 12
SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2805-2812
Closed Access | Times Cited: 11
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2805-2812
Closed Access | Times Cited: 11
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Tissue-resident memory T cells in protective immunity to influenza virus
Seung‐Woo Lee, Karen Yeung, Tania H. Watts
Current Opinion in Virology (2024) Vol. 65, pp. 101397-101397
Open Access | Times Cited: 7
Seung‐Woo Lee, Karen Yeung, Tania H. Watts
Current Opinion in Virology (2024) Vol. 65, pp. 101397-101397
Open Access | Times Cited: 7
Characterizing regional drug delivery within the nasal airways
John Chen, Warren H. Finlay, Reinhard Vehring, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 537-551
Closed Access | Times Cited: 7
John Chen, Warren H. Finlay, Reinhard Vehring, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 537-551
Closed Access | Times Cited: 7
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines
Chunhong Dong, Wandi S. Zhu, Lai Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Chunhong Dong, Wandi S. Zhu, Lai Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets
Ian R. Woodward, Catherine A. Fromen
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 307-330
Closed Access | Times Cited: 6
Ian R. Woodward, Catherine A. Fromen
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 307-330
Closed Access | Times Cited: 6
Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues
Jingjing Liu, Liat Stoler‐Barak, Hadas Hezroni-Bravyi, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 637-646
Open Access | Times Cited: 6
Jingjing Liu, Liat Stoler‐Barak, Hadas Hezroni-Bravyi, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 637-646
Open Access | Times Cited: 6
Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection
Daan K. J. Pieren, Sebastián G. Kuguel, Joel Rosado, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Daan K. J. Pieren, Sebastián G. Kuguel, Joel Rosado, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Nanoparticle-based immunotherapeutics: From the properties of nanocores to the differential effects of administration routes
André Perez‐Potti, Manuel Rodríguez-Pérez, Ester Polo, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114829-114829
Open Access | Times Cited: 14
André Perez‐Potti, Manuel Rodríguez-Pérez, Ester Polo, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114829-114829
Open Access | Times Cited: 14
Nasal delivery as a strategy for the prevention and treatment of COVID-19
Fabio Sonvico, Gaia Colombo, Eride Quarta, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1115-1130
Open Access | Times Cited: 14
Fabio Sonvico, Gaia Colombo, Eride Quarta, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1115-1130
Open Access | Times Cited: 14